A
Araz Rawshani
Researcher at University of Gothenburg
Publications - 85
Citations - 4632
Araz Rawshani is an academic researcher from University of Gothenburg. The author has contributed to research in topics: Medicine & Cardiopulmonary resuscitation. The author has an hindex of 21, co-authored 60 publications receiving 2930 citations. Previous affiliations of Araz Rawshani include Sahlgrenska University Hospital.
Papers
More filters
Journal ArticleDOI
Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
Aidin Rawshani,Araz Rawshani,Stefan Franzén,Björn Eliasson,Ann-Marie Svensson,Mervete Miftaraj,Darren K. McGuire,Naveed Sattar,Annika Rosengren,Soffia Gudbjörnsdottir +9 more
TL;DR: In Sweden from 1998 through 2014, mortality and the incidence of cardiovascular outcomes declined substantially among persons with diabetes, although fatal outcomes declined less among those with type 2 diabetes than among controls.
Journal ArticleDOI
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Aidin Rawshani,Araz Rawshani,Stefan Franzén,Naveed Sattar,Björn Eliasson,Ann-Marie Svensson,Björn Zethelius,Mervete Miftaraj,Darren K. McGuire,Annika Rosengren,Soffia Gudbjörnsdottir +10 more
TL;DR: Patients with type 2 diabetes who had five risk‐factor variables within the target ranges appeared to have little or no excess risk of death, myocardial infarction, or stroke, as compared with the general population.
Journal ArticleDOI
Type 1 Diabetes Mellitus
Anastasia Katsarou,Soffia Gudbjörnsdottir,Araz Rawshani,Dana Dabelea,Ezio Bonifacio,Barbara J. Anderson,Laura M. Jacobsen,Desmond A. Schatz,Åke Lernmark +8 more
TL;DR: A cure is not available, and patients depend on lifelong insulin injections; novel approaches to insulin treatment, such as insulin pumps, continuous glucose monitoring and hybrid closed-loop systems, are in development.
Journal ArticleDOI
Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study.
Araz Rawshani,Naveed Sattar,Stefan Franzén,Aidin Rawshani,Andrew T. Hattersley,Ann-Marie Svensson,Björn Eliasson,Soffia Gudbjörnsdottir +7 more
TL;DR: Age at onset of type 1 diabetes is an important determinant of survival, as well as all cardiovascular outcomes, with highest excess risk in women.
Journal ArticleDOI
Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks Findings From the Swedish National Diabetes Registry
Naveed Sattar,Araz Rawshani,Stefan Franzén,Aidin Rawshani,Ann-Marie Svensson,Annika Rosengren,Annika Rosengren,Darren K. McGuire,Björn Eliasson,Soffia Gudbjörnsdottir +9 more
TL;DR: Age at diagnosis of T2DM is prognostically important for survival and cardiovascular risks, with implications for determining the timing and intensity of risk factor interventions for clinical decision making and for guideline-directed care.